Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > LATEST
LATEST
-
BUSINESS Kyorin Begins Japan PIII Trial of Beova in Pediatric OAB
May 11, 2026
-
BUSINESS Kyowa Kirin Keeps Long-Term KPIs despite OX40 Setback, Ups 2026 Core Profit Outlook
May 11, 2026
-
BUSINESS Onychomycosis Drug Jublia Now Available in Germany: Kaken
May 11, 2026
-
BUSINESS Fujifilm Bags Japan Approval for Meniscus Regenerative Therapy
May 11, 2026
-
BUSINESS Takeda Logs Positive PII/III Results for TAK-881 in PID, Eyes FY2026 Filing
May 11, 2026
-
BUSINESS Kyowa Kirin to Consolidate Domestic Research Sites in Yokohama
May 11, 2026
-
BUSINESS Kissei Sublicenses Taiwan Rights for Rigel’s AML Drug to OEP
May 11, 2026
-
BUSINESS Japan Review Underway for Rhythm’s Acquired Hypothalamic Obesity Drug
May 11, 2026
-
BUSINESS Deciphera Portfolio Powers Ono to Record Sales as It Eyes Post-Opdivo Era
May 11, 2026
-
BUSINESS Daiichi Sankyo Healthcare to Raise Prices of OTC Drugs amid Inflation
May 11, 2026
-
BUSINESS J&J's Drug-Device Combo Offers Weeks-Long Local Therapy for Bladder Cancer: Exec
May 8, 2026
-
REGULATORY MHLW Issues Q&A on Conditional Approval System
May 1, 2026
-
ORGANIZATION JPMA Launches New Legal Entity, Set for October Transition
May 1, 2026
-
BUSINESS Leqembi FY2025 Global Sales Reach 88 Billion Yen: Eisai
May 1, 2026
-
REGULATORY Panel Backs Proposal to Allow Antibody Drugs Like Beyfortus in NIP
May 1, 2026
-
BUSINESS Rohto Files CMV Corneal Endotheliitis Drug in Japan
May 1, 2026
-
BUSINESS Mochida Files in Japan for PAH Drug Tyvaso DPI
May 1, 2026
-
BUSINESS Tanabe Clinches EU Approval for Parkinson’s Drug Onerji
May 1, 2026
-
BUSINESS 3D “Deeply Disappointed” by Toho Plan to Seek Defense Trigger Approval
May 1, 2026
-
BUSINESS Jardiance Tops Four Promotion Channels in March: Intage
May 1, 2026
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…